Ferdinand Huber

Ferdinand Huber began their work experience as a PhD student at Caltech in 2013. During this time, they also served as the Head Teaching Assistant from 2014 to 2019. In 2019, they joined Octapharma as a Scientist in R&D Molecular Design until 2021. Currently, they are working as a Principal Scientist in Protein Therapeutics at Odyssey Therapeutics starting from 2022.

Ferdinand Huber completed their education in a progressive manner. Ferdinand started by obtaining a Bachelor of Science degree in Chemistry and Biochemistry from Ludwig-Maximilians-Universität München, which they pursued from 2007 to 2011. Ferdinand then pursued a Master of Science degree in Biochemistry and Molecular Biology from the same university, from 2011 to 2013. Lastly, they obtained their highest level of education, a Doctor of Philosophy degree in Biochemistry and Molecular Biophysics from Caltech, which they completed from 2013 to 2019.